Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Auroactive Pharma Private Limited, is an unlisted private company incorporated on 09 January, 2020. It is classified as a private limited company and is located in Rangareddi, Telangana. It's authorized share capital is INR 150.00 cr and the total paid-up capital is INR 100.00 cr.
Auroactive Pharma's operating revenue range is Under INR 1 cr for the financial year ending on 31 March, 2023. It's book networth has increased by 256.0%.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR lacs. Based on March 2023 numbers.
256.0%
346.42%
2.04
1.33
0.31
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(1)
| State | Type | Address |
|---|---|---|
| Telangana | Registered Office | Galaxy, Floors 22-24, Plot No. 1, Survey No. 83/1 Hyderaba d Knowledge City, Raidurg Panmak tha NA Hyderabad Rangareddi Telangana - 500032 |
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | ||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2023 available in Tofler Pro
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2023 available in Tofler Pro
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2023 available in Tofler Pro
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|
| Solvency + | ||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | ||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | ||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | ||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | ||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | ||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO |
State Bank of India
No. of Loans: 1
Total Amount : 425.0 cr
Total Amount : 425.0 cr
Charge Date : 31 Jul, 2024
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Sivakumaran Meenakshisunderam | 01284320 | 5 years |
| Director | Santhanam Subramanian | 03516515 | 2 years |
| Additional Director | Deepak Singh | 09786945 | 2 years |
| Director | Mylandlahalli Rammohan Ashwini | 10568862 | 1 years |
| CFO | Vijaya Bhaskar Aravapalli | <HIDDEN> | 3 years |
| Kmp | Srinivas Bodige | <HIDDEN> | 1 years |
| Kmp | Bheemavarapu Siva Rama Krishna Reddy | <HIDDEN> | 2 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| TRIDENT LIFE SCIENCES LIMITED |
Amalgamated
|
1.6 L | 1 | Telangana |
| APL RESEARCH CENTRE LIMITED |
Amalgamated
|
12.3 Cr | 2 | Telangana |
| CUREPRO PARENTERALS LIMITED |
Amalgamated
|
13.3 Cr | 1 | Telangana |
| AUROZYMES LIMITED |
Amalgamated
|
5.0 L | 1 | Telangana |
| AURO PEPTIDES LIMITED |
Active
|
265.9 Cr | 1 | Telangana |
| TERGENE BIOTECH LIMITED |
Active
|
45.0 Cr | 2 | Telangana |
| AUROBINDO PHARMA FOUNDATION |
Active
|
1.0 L | 1 | Telangana |
| EUGIA STERILES PRIVATE LIMITED |
Active
|
44.2 Cr | 2 | Telangana |
| CURATEQ BIOLOGICS PRIVATE LIMITED |
Active
|
100.0 Cr | 2 | Telangana |
| APL HEALTHCARE LIMITED |
Active
|
216.0 Cr | 2 | Telangana |
| THERANYM BIOLOGICS PRIVATE LIMITED |
Active
|
10.0 L | 1 | Telangana |
| QULE PHARMA PRIVATE LIMITED |
Active
|
10.0 L | 1 | Andhra Pradesh |
| APITORIA PHARMA PRIVATE LIMITED |
Active
|
99.0 Cr | 2 | Telangana |
| EUGIA PHARMA SPECIALITIES LIMITED |
Active
|
621.0 Cr | 1 | Telangana |
| EUGIA SEZ PRIVATE LIMITED |
Active
|
4.0 Cr | 2 | Telangana |
| LYFIUS PHARMA PRIVATE LIMITED |
Active
|
10.0 L | 1 | Andhra Pradesh |
| AURO VACCINES PRIVATE LIMITED |
Active
|
10.0 L | 1 | Telangana |
The incorporation date of AUROACTIVE PHARMA PRIVATE LIMITED is 09 January, 2020
The authorized share capital of AUROACTIVE PHARMA PRIVATE LIMITED is INR ₹ 150.0 Cr.
The paid-up capital of AUROACTIVE PHARMA PRIVATE LIMITED is INR ₹ 100.0 Cr.
The registered address of AUROACTIVE PHARMA PRIVATE LIMITED is Galaxy, Floors 22-24, Plot No. 1, Survey No. 83/1 Hyderaba d Knowledge City, Raidurg Panmak tha NA Hyderabad Rangareddi Telangana - 500032
The CIN number of AUROACTIVE PHARMA PRIVATE LIMITED is U24230TG2020PTC138313.
Expand
Delete
Collapse
See
details
